Yahoo · Sep 16, 2026
MO Stock: Altria Returned Billions To Shareholders. What’s The Catch?
A tobacco giant sent a torrent of cash back to its owners. Here’s what that money actually bought, and what has to go right for the checks to keep coming.
NYSE · PM
Philip Morris International Inc.
Consumer Defensive · Tobacco
$194.11
Down-$0.75 (-0.38%)
Updated Sep 16, 2026, 11:53 AM
SID Score
7.6/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 234.96B
- P/E ratio
- 27.29
- Dividend yield
- 2.84%
- 52-week range
- $149.51 – $207.76
- Volume
- 4.18M
- Avg. volume
- 6.58M
Price performance
PM price history
1M range · 20 trading sessions · Daily adjusted prices
PM closed at $194.11 after 20 trading sessions, up 3.46% for the selected period.
- Last close
- $194.11
- Period change
- +3.46%
- Period low
- $182.53
- Period high
- $194.86
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $192.91 | $195.225 | $190.794 | $194.11 | 4.18M |
| Sep 14, 2026 | $195.19 | $195.35 | $192.85 | $194.86 | 2.94M |
| Sep 11, 2026 | $191.34 | $194.82 | $190.555 | $191.06 | 5.32M |
| Sep 10, 2026 | $188.61 | $192.445 | $188.4158 | $189.77 | 4.66M |
| Sep 9, 2026 | $185.50 | $186.28 | $181.55 | $185.71 | 3.95M |
| Sep 8, 2026 | $181.01 | $187.36 | $181.01 | $184.73 | 4.83M |
| Sep 4, 2026 | $185.03 | $185.9711 | $182.23 | $182.53 | 3.16M |
| Sep 3, 2026 | $188.65 | $189.085 | $186.065 | $186.17 | 2.76M |
| Sep 2, 2026 | $187.36 | $189.21 | $184.75 | $187.94 | 2.94M |
| Sep 1, 2026 | $190.35 | $192.3709 | $187.07 | $187.15 | 4.13M |
| Aug 31, 2026 | $190.78 | $191.00 | $186.99 | $187.30 | 4.01M |
| Aug 28, 2026 | $191.15 | $192.8528 | $190.20 | $191.89 | 3.82M |
| Aug 27, 2026 | $191.89 | $193.635 | $190.16 | $190.48 | 3.98M |
| Aug 26, 2026 | $195.00 | $196.66 | $192.6343 | $194.10 | 4.58M |
| Aug 25, 2026 | $190.87 | $194.18 | $189.66 | $193.92 | 2.72M |
| Aug 24, 2026 | $190.24 | $193.47 | $189.1701 | $191.46 | 4.68M |
| Aug 21, 2026 | $190.97 | $191.09 | $187.99 | $188.23 | 4.09M |
| Aug 20, 2026 | $188.83 | $194.26 | $188.83 | $191.52 | 5.37M |
| Aug 19, 2026 | $188.71 | $190.50 | $186.8054 | $189.93 | 4.8M |
| Aug 18, 2026 | $187.03 | $188.87 | $186.01 | $187.62 | 7.11M |
Latest PM news
The latest Smart Investors Daily articles mentioning PM.
Stock researchCompany · Overview
PM research
Overview
Company profile and research snapshot.
Company profile
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $178.67
- Implied upside
- —
- Analysts
- 8
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Citigroup | Buy | — |
| Jul 29, 2026 | Barclays | Overweight | — |
| Jul 23, 2026 | Morgan Stanley | Overweight | — |
| Jul 23, 2026 | Stifel | Buy | — |
| Jul 23, 2026 | Needham | Buy | — |
News briefing
Generated Sep 15, 2026, 9:25 PM
Why Is PM Down Today?
Philip Morris International (PM) declined 0.38% today amid a mixed backdrop of earnings reviews and company developments that failed to generate significant positive momentum. While the tobacco giant continues to demonstrate operational strength through workforce expansion and pricing power, the broader market sentiment remains cautiously neutral as investors digest Q2 results alongside industry-wide headwinds.
Bottom line: Philip Morris shows operational resilience with strong pricing power and strategic workforce investments, but today's modest decline reflects a market that remains skeptical about growth prospects in a structurally declining tobacco category. Investors should monitor whether the company's transition to reduced-risk products can materialize into meaningful revenue growth, while the current dividend yield continues to support long-term holders despite near-term volatility.
Yahoo · Sep 15, 2026
Trump’s Surgeon General Pick Loves These 3 Tobacco Stocks
Nicole Saphier is invested in Philip Morris International, Altria, and British American Tobacco.
Yahoo · Sep 15, 2026
Q2 Earnings Highlights: Philip Morris (NYSE:PM) Vs The Rest Of The Beverages, Alcohol, and Tobacco Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the beverages, alcohol, and tobacco stocks, including Philip Morris (NYSE:PM) and its peers.
Yahoo · Sep 15, 2026
Altria's Price Realization at 4.5%: Can Pricing Momentum Stay Strong?
MO's smokeable products pricing remained strong, but rising discount volumes and Basic's growth continued to weigh on the overall product mix.
AI research layers
Interpretive context generated from the platform’s current data sources.
Philip Morris International Inc. Stock Performance
Philip Morris International Inc. shares closed at $194.11, reflecting a daily decline of 0.73%, per SID market data. Despite the session pullback, the stock has demonstrated consistent strength across multiple timeframes, gaining 1.95% over the past month, 6.77% over three months, and 28.59% over the trailing twelve months. The stock currently trades above both key moving averages, with the 50-day moving average at $188.95 and the 200-day moving average at $179.26, indicating sustained upward momentum according to Massive/Polygon technical data. The 14-day relative strength index sits at 50.3, placing PM in neutral territory and suggesting neither overbought nor oversold conditions. Average daily trading volume stands at approximately 6.58 million shares, supporting adequate liquidity. The stock's beta of 0.436 reflects significantly lower volatility than the broader market, consistent with its Consumer Defensive sector classification and its appeal as a defensive holding.
Philip Morris International Inc. Valuation Analysis
Philip Morris International carries a market capitalization of approximately $234.96 billion, positioning it among the largest Consumer Defensive companies globally, per SID market data. The stock trades at a price-to-earnings ratio of 27.29, which is elevated relative to traditional tobacco sector peers and reflects the market's pricing of PM's transition toward reduced-risk products. The PEG ratio stands at 5.76, according to SEC filings, indicating the current P/E significantly exceeds the company's earnings growth rate. Notably, Philip Morris reports a negative price-to-book ratio of -21.53, a consequence of accumulated share buybacks and dividend distributions that have driven stockholders' equity into negative territory on its balance sheet. The company maintains a dividend yield of 3.66%, providing income-oriented investors with a substantial payout. The premium valuation metrics suggest the market is pricing in sustained revenue growth from PM's smoke-free product portfolio, particularly its IQOS and ZYN brands.
Smart Money Activity for PM
Philip Morris International registers a composite smart money score of 54 out of 100, generating a Neutral signal per SID market data. The institutional component scores a perfect 25 out of 25, indicating maximum institutional ownership and conviction among large fund managers. This stands in contrast to dark pool activity, which scores only 5.0 out of 25, suggesting limited off-exchange block trading in recent periods. Insider activity scores 12.5 out of 25, reflecting moderate corporate insider transaction levels according to SEC Form 4 filings. Congressional trading activity registers at 12 out of 25, indicating some legislative interest in PM shares but without a pronounced directional bias. The divergence between institutional strength and subdued dark pool activity is notable; the perfect institutional score of 25 confirms that major asset managers maintain significant positions, per 13F institutional filings. However, the lower dark pool and insider readings temper the overall signal, resulting in the composite Neutral classification rather than a bullish reading.
Philip Morris International Inc. Earnings Outlook
Philip Morris International has delivered consecutive earnings beats across its three most recent reporting periods, per company earnings reports. In the most recent quarter reported on July 22, 2026, PM posted earnings per share of $2.20 versus the consensus estimate of $2.05, representing a positive surprise of $0.15 or approximately 7.3%. The prior quarter saw EPS of $1.96 against estimates of $1.82, a $0.14 beat, while the quarter reported in February 2026 produced EPS of $1.70 versus the $1.69 estimate, a modest $0.01 surprise. Analyst estimates project earnings of $2.05 per share for the upcoming quarter scheduled for July 21, 2026. The pattern of accelerating beat magnitudes across the three reported quarters suggests improving operational execution. These results underscore PM's ability to consistently exceed Wall Street expectations, driven by the ongoing expansion of its smoke-free product portfolio and favorable pricing dynamics.
Wall Street Analyst Ratings for PM
Wall Street consensus on Philip Morris International remains unanimously bullish, with all five most recent analyst actions reaffirming positive ratings, according to Wall Street analyst reports. On July 30, 2026, Citigroup reiterated its Buy rating, followed by Barclays maintaining its Overweight designation on July 29. In the immediate aftermath of PM's earnings release, three firms issued concurrent reaffirmations on July 23: Morgan Stanley maintained Overweight, Stifel reiterated Buy, and Needham upheld its Buy rating, per SID consensus data. Notably, none of the five actions represented upgrades or downgrades, as each firm maintained prior ratings, indicating stable long-term conviction rather than reactive positioning. The clustering of three reaffirmations on the earnings date reflects analyst confidence in PM's reported results. The absence of any Hold or Sell ratings among recent coverage actions demonstrates broad institutional agreement on the company's growth trajectory, particularly as its reduced-risk product segments continue gaining market share globally.
